Detail akcie China Pharma Rg online

Business Summary: China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2024, China Pharma Holdings Inc revenues decreased 35% to $4.5M. Net loss increased 54% to $4.7M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Amortization of Intangibles Assets increase of 100% to $447K (expense), General and administrative expenses - Ba increase of 8% to $1.3M (expense).